New meningitis vaccine shows promise in toddler trial
NCT ID NCT03890367
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 24 times
Summary
This study tested a new meningitis vaccine (MenACYW Conjugate) in healthy toddlers aged 12 to 23 months. The goal was to see if it works as well as or better than two existing vaccines (Nimenrix and NeisVac-C) at protecting against meningococcal serogroup C. The study involved 707 toddlers and measured their immune response through blood tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGOCOCCAL IMMUNISATION (HEALTHY VOLUNTEERS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number 2080001
Aarhus, 8200, Denmark
-
Investigational Site Number 2080002
Hvidovre, 2650, Denmark
-
Investigational Site Number 2080003
Odense, 5000, Denmark
-
Investigational Site Number 2460001
Tampere, 33100, Finland
-
Investigational Site Number 2460002
Turku, 20520, Finland
-
Investigational Site Number 2460003
Pori, 28100, Finland
-
Investigational Site Number 2460004
Jarvenpaa, 04400, Finland
-
Investigational Site Number 2460005
Helsinki, 00100, Finland
-
Investigational Site Number 2460006
Espoo, 02230, Finland
-
Investigational Site Number 2460007
Oulu, 90220, Finland
-
Investigational Site Number 2460008
Kokkola, 67100, Finland
-
Investigational Site Number 2460010
Seinäjoki, 60100, Finland
-
Investigational Site Number 2760002
Erfurt, 99086, Germany
-
Investigational Site Number 2760003
Mönchengladbach, 41236, Germany
-
Investigational Site Number 2760004
Bramsche, 49565, Germany
-
Investigational Site Number 2760005
Mönchengladbach, 41236, Germany
-
Investigational Site Number 2760006
Schönau, 83471, Germany
-
Investigational Site Number 2760007
Hürth, 50354, Germany
-
Investigational Site Number 2760008
Schwaigern, 74193, Germany
-
Investigational Site Number 2760009
Schweigen, 76889, Germany
-
Investigational Site Number 2760010
Tuttlingen, 78532, Germany
-
Investigational Site Number 2760011
Mannheim, 68161, Germany
-
Investigational Site Number 2760012
Wolfsburg, 38448, Germany
-
Investigational Site Number 2760013
Itzehoe, 25524, Germany
-
Investigational Site Number 2760015
Bönnigheim, 74357, Germany
-
Investigational Site Number 2760017
Hamburg, 22415, Germany
-
Investigational Site Number 2760018
Tauberbischofsheim, 97941, Germany
-
Investigational Site Number 2760019
Bretten, 75015, Germany
-
Investigational Site Number 2760020
Herxheim, 76863, Germany
Conditions
Explore the condition pages connected to this study.